Company Profile: China Nepstar Chain Drugstore and its subsidiaries operate retail drugstores in China.
Dividend Yield: 8.9% (forward annual)Closing price: $3.11 (Sept. 10) Financial Metrics: China Nepstar has a price-to-book ratio of 1.42, which indicates the stock may be slightly overvalued based on book value. China Nepstar's quick ratio, which measures the ability to meet short-term obligations with its most liquid assets, is 2.4, indicating the drugstore company would be able to meet its current liabilities. Analyst Consensus: Five analysts follow China Nepstar, although only one firm (Roth Capital Partners) says investors should buy the stock. Another two firms, including Goldman Sachs, have a "hold" or "neutral" rating on the stock, while two analysts rate China Nepstar a "sell."